Cargando…
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer
Autores principales: | Tanyi, Janos L., Chiang, Cheryl L.-L., Chiffelle, Johanna, Thierry, Anne-Christine, Baumgartener, Petra, Huber, Florian, Goepfert, Christine, Tarussio, David, Tissot, Stephanie, Torigian, Drew A., Nisenbaum, Harvey L., Stevenson, Brian J., Guiren, Hajer Fritah, Ahmed, Ritaparna, Huguenin-Bergenat, Anne-Laure, Zsiros, Emese, Bassani-Sternberg, Michal, Mick, Rosemarie, Powell, Daniel J., Coukos, George, Harari, Alexandre, Kandalaft, Lana E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096937/ https://www.ncbi.nlm.nih.gov/pubmed/33947868 http://dx.doi.org/10.1038/s41541-021-00332-5 |
Ejemplares similares
-
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer
por: Tanyi, Janos L., et al.
Publicado: (2021) -
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity
por: Fritah, Hajer, et al.
Publicado: (2023) -
Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013) -
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines
por: Graciotti, Michele, et al.
Publicado: (2020) -
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
por: Kandalaft, Lana E., et al.
Publicado: (2013)